脓毒症炎症表型中ARDS的死亡原因及归因分数
该研究纳入两个前瞻性队列共1737例脓毒症患者,患者此前已通过潜在类别分析被分为高炎症或低炎症表型。研究分别在两种表型中估算脓毒症患者ARDS的人群归因死亡分数(PAFARDS)。在EARLI队列死亡患者亚组(n=130/179)中,从病历中提取器官功能障碍、严重合并症和撤除生命支持情况。结果显示,低炎症脓毒症PAFARDS为19%(95%CI 10,28%),高炎症脓毒症为14%(95%CI 6,20%);两种表型死因不同(p<0.001),低炎症以呼吸衰竭最常见,高炎症以循环休克最常见;低炎症脓毒症中合并严重基础疾病死亡更常见(81% vs. 67%,p=0.004)。
要点
- 低炎症脓毒症中ARDS归因死亡分数为19%(95%CI 10,28%),高炎症脓毒症中为14%(95%CI 6,20%)。
- 两种表型的死因分布不同(p<0.001):低炎症脓毒症以呼吸衰竭为最常见死因,高炎症脓毒症以循环休克为最常见死因。
- 低炎症脓毒症中合并严重基础疾病死亡的比例高于高炎症脓毒症(81% vs. 67%,p=0.004)。
- 研究提示未来临床试验在脓毒症和ARDS患者中检测死亡率变化存在把握度方面的挑战。
适用人群与场景
- 两个前瞻性队列中既往经潜在类别分析分为高炎症或低炎症表型的1737例脓毒症患者。
- 死因分析亚组来自EARLI队列死亡患者(n=130/179),从病历中提取器官功能障碍、严重合并症和撤除生命支持情况。
研究设计与关键结果
- 研究纳入两个前瞻性队列1737例脓毒症患者,患者此前已用潜在类别分析分为高炎症或低炎症表型。
- PAFARDS在低炎症脓毒症中为19%(95%CI 10,28%),在高炎症脓毒症中为14%(95%CI 6,20%)。
- 两种表型死因不同(p<0.001):低炎症脓毒症以呼吸衰竭为最常见死因,高炎症脓毒症以循环休克为最常见死因。
- 低炎症脓毒症中合并严重基础疾病死亡更常见(81% vs. 67%,p=0.004)。
- 研究提示未来临床试验在脓毒症和ARDS患者中检测死亡率变化存在把握度方面的挑战。
证据类型、等级与局限
- 证据类型:两个前瞻性队列研究。
- 局限:原文未报告局限性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「对床旁实践的改变」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Hypoinflammatory and hyperinflammatory phenotypes have been identified in both Acute Respiratory Distress Syndrome (ARDS) and sepsis. Attributable mortality of ARDS in each phenotype of sepsis is yet to be determined. We aimed to estimate the population attributable fraction of death from ARDS (PAFARDS) in hypoinflammatory and hyperinflammatory sepsis, and to determine the primary cause of death within each phenotype.
METHODS: We studied 1737 patients with sepsis from two prospective cohorts. Patients were previously assigned to the hyperinflammatory or hypoinflammatory phenotype using latent class analysis. The PAFARDS in patients with sepsis was estimated separately in the hypo and hyperinflammatory phenotypes. Organ dysfunction, severe comorbidities, and withdrawal of life support were abstracted from the medical record in a subset of patients from the EARLI cohort who died (n = 130/179). Primary cause of death was defined as the organ system that most directly contributed to death or withdrawal of life support.
RESULTS: The PAFARDS was 19% (95%CI 10,28%) in hypoinflammatory sepsis and, 14% (95%CI 6,20%) in hyperinflammatory sepsis. Cause of death differed between the two phenotypes (p < 0.001). Respiratory failure was the most common cause of death in hypoinflammatory sepsis, whereas circulatory shock was the most common cause in hyperinflammatory sepsis. Death with severe underlying comorbidities was more frequent in hypoinflammatory sepsis (81% vs. 67%, p = 0.004).
CONCLUSIONS: The PAFARDS is modest in both phenotypes whereas primary cause of death among patients with sepsis differed substantially by phenotype. This study identifies challenges in powering future clinical trials to detect changes in mortality outcomes among patients with sepsis and ARDS.
参考来源
- Evrard B, Sinha P, Delucchi K, et al. Causes and attributable fraction of death from ARDS in inflammatory phenotypes of sepsis. Crit Care. 2024. PMID: 38745253. doi:10.1186/s13054-024-04943-x
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。